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Abstract--Previous work has demonstrated that nitric oxide can be an important intracellular messenger 
in the regulation of neurosecretion in chromaffin cells. Since standard chromaffin cell cultures are mixed 
populations of noradrenaline and adrenaline producing cells, it would seem important to understand the 
functional differences between these individual components. The use of fluorescence imaging techniques 
for the recording of cytosolic alcium from single chromaffin cells together with the immunoidentification 
of individual cells with specific antibodies against yrosine hydroxylase, N-phenyl ethanolamine methyl 
transferase and nitric oxide synthase, has allowed us to measure single-cell calcium responses in identified 
adrenergic, noradrenergic and nitrergic hromaffin cells, thus helping us to clarify the differential role 
of nitric oxide in the function of these chromaffin cell types. 53-4-2%° of chromaffin cells were able 
to synthesize nitric oxide (nitric oxidesynthase-positive cells), these cells being mainly noradrenergic 
(82 ± 2%0). Results indicate that nitric oxide donors such as sodium nitroprusside, molsidomine and 
isosorbide dinitrate voke [Ca2+]± increases in a 62 ± 4% of chromaffin cells, the response to nitric oxide 
donors being between 30 and 50% of that of 20 ~tM nicotine. Cells responding to nitric oxide donors were 
mainly adrenergic (68±5%) although 45+9% of noradrenergic cells also gave [Ca2+]± increasing 
responses. The distribution of nitric oxide responding cells between itric oxide synthase-positive and 
negative was very similar in the whole population (63 ± 5 and 60 ± 7%, respectively), but these differences 
were more prominent when considering the distribution of nitric oxide response between oradrenergic 
and adrenergic nitric oxide synthase-positive cells; while 73 i 6% of adrenergic nitric oxide synthase- 
positive cells evoke [Ca2+]i increases by nitric oxide stimulation, only 35 ± 11%o of noradrenergic nitric 
oxide synthase-positive cells respond. 
Taken together these results eem to indicate that (i) nitric oxide could act within adrenal medulla as 
both an intracellular and intercellular messenger; and (ii) noradrenergic cells seem to be specialized in 
nitric oxide synthesis while adrenergic ells with an endocrine function could mainly act as a target of 
neurosecretory action of this second messenger. © 1997 IBRO. Published by Elsevier Science Ltd. 
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Nitric oxide (NO) is a short-lived, highly reactive 
radical, originally identified as both a mediator in 
vasodi latat ion 22 and an active agent in macrophage 
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cytotoxicity. 25 In addit ion NO has been shown to 
function as a central and peripheral neuronal  mess- 
enger or putative neurotransmitter  involved in crucial 
physiological events such as neurotransmitter  
release, 13 long-term potentiat ion 12 and gene tran- 
scription, 11"3~ as well as in the pathophysiological 
events underlying neurotoxicity} "37 
In central and peripheral neurons NO is synthe- 
sized from L-arginine by the neural isoform of 
nitric oxide synthase (nNOS), which is structurally, 
immunological ly and functionally different from 
the isoforms expressed constitutively in vascular 
endothelial cells or upon induction in macrophages.lS 
The presence of this enzyme has been shown in 
different peripheral neural tissues by both biochemi- 
cal analysis and immunofluorescence techniques.~ In
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these tissues NO plays its physiological functions by 
activation of a soluble guanylate cyclase resulting in 
formation of cGMP.  
In the adrenal medulla, a tissue of ectodermic 
origin (as are neurons), the existence of a complete 
pathway L-arginine/NO/cGMP has been demon- 
strated. The presence of NOS has been shown 
in bovine chromaffin cells by both biochemical 
methods demonstrat ing the formation of bcitrul l ine 
from L-arginine 27"3° and by immunohistochemical  
methods using antisera raised against purified soluble 
nNOS 3 or cytochemical techniques showing a specific 
staining for NADPH-diaphorase.  27 By using these 
techniques its presence has been also assessed in adult 
rat adrenal gland in almost all choline acetyltrans- 
ferase (ChAT)-posit ive fibres and ChAT/enkephal in 
preganglionic fibres running in the splanchnic 
nerves 16 and in small intra-adrenal non-cholinergic/ 
non-adrenergic ganglion neurons which express 
vasoactive intestinal polypeptide-like immuno- 
reactivity that are scattered between chromaffin 
cells. ') In human adrenal medulla, immunoreactivity 
for NOS has also been demonstrated in neurons, 
nerve fibres and chromaffin cells, co-localizing with 
substance P only and not with neuropeptide Y and 
somatostatin. ~5 The location of NOS in distinct 
structural compartments of the rat and human adre- 
nal medulla indicates that NO is produced in differ- 
ent cell types and may reflect a difl'erential role of this 
messenger system in autonomic control of adrenal 
gland function. 
Concerning the role of NO in the regulation of 
adrenal medulla function previous work indicates 
that nitrergic compounds 7 or pure NO 27 activate 
basal and inhibit nicotine-evoked catecholamine 
secretion. However, while there is general agreement 
with the fact that NO pure gas, 27 NO-generat ing 
compounds and cGMP 2~j32'33 decrease both catecho- 
lamine secretion and intracellular free calcium con- 
centration ([Ca2+]i) increases evoked by depolarizing 
stimuli like ace@choline, nicotine and high KCI, 
there are contradictory results concerning the effect 
of NO on basal catecholamine secretion and [Ca2+]i 
since some authors failed to find any effect of NO on 
catecholamine secretion by itself. 24"2'~'32"33 In dis- 
agreement with these positive observations, Marley 
et aL e° failed to find specific staining for NADPH-  
diaphorase and nNOS in adrenal medullary chrom- 
affin cells and nerve fibres or any effect of NO in 
adrenaline and noradrenal ine secretion evoked by 
electric field stimulation, concluding that NO does 
not play a direct role in the acute regulation of 
adrenal catecholamine secretion. 
All these results show that the effect of NO on the 
function of chromaffin cells is more complex than it 
previously seemed and it is far from being clear. A 
major source of uncertainty that may explain, at least 
in part, these conflicting results, may be the known 
cellular heterogeneity of bovine adrenal medulla and 
chromaffin cell cultures. 1°'2-~ Functionally different 
responses to histamine and angiotensin I1, 5"2(' ATP 4 
and Ca 2+'35 were demonstrated among adrenergic 
and noradrenergic or ganglionar cells co-existing in 
these mixed cultures. So, given this heterogeneity it 
seems very important to investigate the possible 
functional differences between these cellular types 
with respect o NO action. For example, it is import- 
ant to know if NO-evoked responses are limited to a 
unique populat ion of noradrenergic or adrenergic 
chromaffin cells and if they correspond to NO- 
producing (NOS +) or non-producing (NOS ) 
chromaffin cells. 
Since a key messenger in the neurosecretory func- 
tion of chromaffin cells is Ca 2+, whose signalling 
pathways are deeply involved in these as well as many 
other neuronal processes, 21 we have combined the 
fluorescence imaging techniques for the recording of 
cytosolic tYee calcium from single chromaffin cells 
with the immunoidentif ication of individual cells 
using specific antibodies against yrosine hydroxylase 
(TH), phenyl ethanolamine N-methyl transferase 
(PNMT)  and nNOS, in order to be able to ascribe 
single cell calcium responses to identified chromaflin 
cells. It has helped us to clarify the differential role of 
NO in the function of adrenaline and noradrenal ine 
secreting cells as well as in NO-producing cells. 
EXPERIMENTAL PROCEDURES 
Cell culture 
Bovine chromaffin cells were obtained essentially in the 
same way as described previously, s-: Briefly, after digestion 
by retrograde perfusion with collagenase the medullary 
tissue was collected, disgregated and chromaflin cells puri- 
fied in a Percoll density gradient. The cells were plated onto 
16 mm round coverslips coated with poly-L-lysine. Chrom- 
altin cells were maintained under a 5% COJ95% air humidi- 
fied atmosphere at 37°C in a 1:1 mixture of Dulbecco's 
modified Eagle's medium (DMEM)/F-12 medium supple- 
mented with 15 mM HEPES, 25 mM NaHCO> 5% inacti- 
vated foetal calf serum, penicillin and streptomycin. Cells 
were typically used between days 2 and 6 after plating. 
Micr(~[tuorescence s t-u~) 
The [Ca'+]~ was measured with the fluorescent probe 
Fura-2. The covcrslips containing the cells were washed in 
physiological saline containing (in mM): 120 NaCI, 5 KC1, 
25 NaHCO 3, 2 CaCI> 1 MgC12 and 10 glucose. The solution 
was constantly gassed with 95% O2/5% CO2 for a final pH 
of 7.4. Chromaffin cells were loaded with 2.5 btM Fura- 
2/AM for 45 rain at 37°C in this medium supplemented 
with 1% bovine serum albumin (BSA). After washing, the 
coverslip was glued to the bottom of a small (approx. 
100 gl) perifusion chamber and placed in the stage of a 
Nikon Diaphot TMD microscope. The cells were continu- 
ously perifused (approx. 1.5 ml/min) with gassed physio- 
logical saline. The drugs were applied for short periods 
(15 60 s) dissolved in the perifusion medium with the aid of 
a l\mr-way stopcock. 
Measurement ()/' [ Cu2+]i t~y video imaging 
The fluorescence changes were recorded with a multiple 
excitation MagiCal imaging system (Applied Imaging, 
U.K.). Chromaffin cells were alternately excited at 340 nm 
and 380 nm by means of a stepping filter wheel and the 
epifluorescence optics of the microscope. Emitted fluor- 
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escence collected with a 20 x objective was driven to a 
Photonics Science SIT camera after passing through a 
510 nm bandpass filter. Eight frames (approx. 100 ms expo- 
sure) were averaged to produce each image. Alternative 
excitation, image capture and processing were controlled by 
a single processor in the MagiCal system. Image analysis 
was performed with MagiCal software and custom-made 
programs (developed by E.C., details available on request). 
Essentially, background fluorescence at each wavelength 
(obtained from a field devoid of cells in each coverslip) was 
subtracted and fluorescence images ratioed on a pixel-by- 
pixel basis. Ratio data were stored as 8-bit pseudocoloured 
images. A contour was drawn around each cell in a field and 
the averaged ratio value of pixels inside each contour 
evaluated at each time point, in order to obtain ratio vs time 
plots for all cells. 
lmmunoeytochemical identification of chromaffin cells 
To study the distribution of NOS, the cells were double 
immunostained with antibodies against NOS (mouse mono- 
clonal anti-NOS) and either TH or PNMT (rabbit poly- 
clonals anti-TH and anti-PNMT). Briefly, cells were fixed 
for 2 min in ice-cold 1:1 acetone:methanol mixture. After 
blocking in phosphate-buffered saline (PBS) with 3% BSA/ 
0.1% Triton X-100, the preparation was incubated with 
primary antibodies (mouse anti-NOS hl00, rabbit anti-TH 
or anti-PNMT 1:500) for 1 h at room temperature. After 
washing in 0.1% Triton X-100, secondary antibodies were 
added [fluorescein isothiocyanate (FITC)-labelled goat 
anti-mouse IgG and tetramethylrhodamine isothiocyanate 
(TRITC)-labelled goat anti-rabbit IgG at 1:200] and incu- 
bated for another hour. 
To identify the cells responding to NO donors, triple 
labellings with mouse anti-NOS, rabbit anti-PNMT and 
mouse anti-TH (monoclonal) were performed in the same 
coverslips used for [Ca2+]~ measurements. Once the [Ca2+]i 
experiments had been performed the cells were fixed with 
50% acetone:50% methanol (v/v) for 1 2 min at 4°C, fol- 
lowed by freezing and storage at -20°C until processing. 
For the immunofluorescence assay, the fixed coverslips 
were thawed by placing them in ice-cold 50% acetone:50% 
methanol and warmed until at room temperature; all the 
following procedures were performed at this temperature. 
The preparation was first processed as for double labelling 
using anti-NOS and anti-PNMT primary antibodies and 
FITC- and TRITC-secondary antibodies. After washing, 
the preparation was fixed again in hl  acetone:methanol in 
order to denaturalize the already bound mouse anti-NOS 
primary antibody t4 and processed for labelling with mouse 
anti-TH (1:50) and 7-amino-4-methyl-coumarin-3-acetic 
acid (AMCA)-conjugated anti-mouse IgG (1:100). The 
coverslips were mounted in 50% glycerol in PBS containing 
2.5% diazabicyclo[2,2,2]octane (DABCO) and digital 
images taken with the same MagiCal system used for Ca 2+ 
experiments. 
Statis'tical nalysis 
Fluorimetric data are expressed as mean -- S.E.M. net 
ratio increases. Statistical comparisons between means were 
performed with a Student's t-test. Immunocytochemical 
data are expressed as number of cells counted and as 
proportion +S.D. of labelled cells vs total cells. S.Ds were 
calculated assuming a binomial distribution of counted 
cells. Comparisons between proportions in 2 x 2 tables were 
done with a )~2 test]9 Table 3 was analysed with a bivariate 
ANOVA approach followed by Z 2 tests of individual 
rows. 34 
Materials" 
Fura2/AM was from Molecular Probes (Eugene, OR, 
U.S.A.) and collagenase was from Boehringer Mannheim 
S.A. (Barcelona, Spain). DMEM and fetal calf serum were 
purchased from GIBCO (BRL, U.K.). Antibiotics were 
supplied by Flow Laboratories Ltd (Irvine, CA, U.S.A.). 
Sodium nitroprusside (SNP), isosorbide dinitrate (ISDN), 
molsidomine, BSA and anti-IgG-FITC and TRITC second- 
ary antibodies were obtained from Sigma Chemical 
(Madrid, Spain). Mouse monoclonal anti-nNOS IgG was 
from Affinity Research Products Ltd (Nottingham, U.K.). 
Rabbit polyclonals anti-TH and rabbit anti-PNMT were 
from Eugene Technology International, mouse monoclonal 
anti-TH was from Boehringer Mannheim S.A. and AMCA- 
conjugated anti-mouse IgG from Calbiochem (San Diego, 
CA, U.S.A.). All other reagents were from Merck 
(Darmstadt, Germany). 
RESULTS 
Nitric oxide donors evoke [Ca2+]i rises in a sub- 
population of chromaffin cells" 
We observed rapid NO-donor  induced changes in 
[Ca2+]i n individual chromaffin cells (Fig. 1) with the 
aid of digital imaging fluorescence microscopy. The 
stimulation with these NO-donors  produced different 
types of time courses, sometimes mono-  and other 
times multi-phasic peaks. Representative time 
courses of changes in [Ca2+]i n a few cells are shown 
in Fig. 1. The most common pattern of response 
encountered after 100 ~aM molsidomine stimulation 
was a moderately increasing signal reaching a plateau 
(Fig. 1A). In contrast with 100 p,M SNP and ISDN 
the most common pattern of response was a transient 
(mono or biphasic) peak returning to basal levels 
after removing the compound (Fig. 1B, C). The 
resting [Ca2+]~ was about 197+43nM in normal 
medium containing 2.5 mM CaC12. Stimulation of 
cells with 100 ~M molsidomine, SNP or ISDN (the 
dose that doubled NO z product ion levels), resulted 
in a net increase in the Fura-2 F34o/F3s o ratio of 
between 0.25 and 1.25 (about 50 and 450 nM), the 
more efficient agonist being molsidomine (Fig. 1A). 
The time course of calcium responses was different 
after challenging cells with 20 ~tM nicotine. In this 
case, all the cells displayed rapidly increasing ratio 
transients that gradually decayed after washing the 
agonist and with peak heights larger than those 
obtained with NO-donors.  The calcium increases in 
the case of NO-donors  represented between 30 and 
50% of the [CaZ+]i rises obtained with 20 ~tM nicotine 
in the same cells. 
The frequency histograms howing the distr ibution 
of the three NO-donor  increases in Fura-2 ratios 
(A ratio) in the whole chromaffin cell populat ion 
are shown in Fig. 2. F rom the total chromaffin 
cell populat ion the 57% responded to 100~tM 
molsidomine, 36% to 100~tM SNP and 37% to 
100 ~M ISDN (Fig. 2). The maximal average ratio 
increase corresponded to molsidomine (0.52+0.08, 
mean+ S.E.M.), followed by SNP (0.45+0.04) and 
ISDN (0.4+0.05), respectively. These parameters 
were collected from nine different experiments on 
a total of 125 chromaffin cells, among which 78 
responded to NO-donors  (62 ± 4%). 
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Fig. 1. Time courses of changes in [Ca2+]i in individual chromaffin cells in response to stimulation with 
different NO-donors. Cells placed in a perifusion chamber in the stage of the microscope were imaged 
through a 20 × fluor objective. The cells were stimulated with (A) 100 ~tM molsidomine, (B) 100 ~tM SNP 
and (C) 100 ~tM ISDN for a 60 s period. Pairs of images of fields were captured at 1.5 s intervals and the 
F340/F380 ratio for each cell in the field was determined on a pixel by pixel basis as described in 
Experimental Procedures. Traces show representative examples of typical F34JF38 o ratio responses of 
individual cells and correspond to different fields during different experiments. The lines show the 
application period of the different NO-donors. 
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Nitric oxide synthase synthesizing cells can be ident- 
ified by nitric oxide synthase immunocytochemistry 
The immunoidentification f chromaffin cells was 
carried out by treatment of fixed chromaffin cells 
with different specific antibodies against TH, the 
rate-limiting enzyme for catecholamine biosynthesis 
(which stains the total chromaffin cell population), 
PNMT,  the regulatory enzyme of adrenaline biosyn- 
thesis (marker of adrenergic population of chrom- 
affin cells) and for nNOS, enzyme responsible for NO 
biosynthesis and marker of nitrergic ells. Noradren- 
ergic cells were those stained by anti-TH but not by 
ant i -PNMT antibodies. 
Figure 3 shows the immunofluorescence images 
of chromaffin cells identified by double or triple 
immunostaining, in a total of 971 cells, with anti- 
nNOS and anti-TH antibodies (Fig. 3A, represen- 
tative of 450 cells), anti-nNOS and ant i -PNMT 
antibodies (Fig. 3B, representative of 396 cells) and 
anti-TH, anti-nNOS and ant i -PNMT antibodies 
(Fig. 3C, representative of 125 cells). 
By combining all the data from double and triple 
immunostainings we obtained the relative propor- 
tions of NOS + cells among adrenergic and noradren- 
ergic populations shown in Table 1. NOS ÷ cells 
comprise 53 ± 2% of the total population (Table 1A). 
NOS was preferentially expressed by noradrenergic 
cells (82 4-2% NOS+), while adrenergic ells show a 
much lower expression of this enzyme (26+3% 
NOS +) (Table 1B). The relative proportions of adren- 
ergic and noradrenergic cells in total chromaffin cell 
population were 50+2% in both cases (Table 1B). 
This proportion was quite different in NOS-  and 
NOS + cells; whereas in NOS cells there was a 
greater proportion of adrenergic (81 +2.5%, against 
19±2.5%), most of NOS + cells (76±2.5%) were 
noradrenergic (Table 1B). 
Distribution of chromaffin cell response to nitric oxide- 
donors in different chromaffin cell populations 
Once we had the possibility of immunoidentifying 
the type of chromaffin cell as either adrenergic/ 
noradrenergic or nitrergic/non-nitrergic we were able 
to assign single-cell calcium responses to identified 
chromaffin cells. 
Table 2 shows the relative proportion of NO- 
donor responsive cells among adrenergic and 
noradrenergic chromaffin cells. From a total of 125 
immunoidentified chromaffin cells in which Fura-2 
ratio was measured, only a 62+4% of the total 
population showed increases in Fura-2 ratio (Table 
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Fig. 2. Distribution of chromaffin cell Fura-2 calcium 
response to NO-donors in the whole chromaffin cell popu- 
lation. Frequency histograms how the distribution of 
increases in Fura-2 ratio (A ratio) evoked by (A) 100 p.M 
molsidomine, (B) 1001aM SNP and (C) 100gM ISDN 
measured as indicated in Experimental Procedures. Data 
are results from the analysis of 125 cells of which 624-4% 
showed clear responses toNO-donors. First bars represent 
those cells unresponsive to NO donors. A log-normal 
distribution was fitted to the histogram representing re- 
sponding cells. The average A ratio and ± 2 S.D. confidence 
limits for mean increase are shown by the point and lines 
above the histograms. 
2A). This proportion of NO-donor responsive cells 
was quite similar in adrenergic cells (68 + 5%) while in 
noradrenergic cells the proportion was significantly 
reduced, only 45 + 9% of cells displayed increases in 
Fura-2 ratios (Table 2B). 
Figure 4A, B shows the frequency histograms 
reflecting the distribution of 100 gM molsidomine- 
evoked ratio increase responses in adrenergic and 
noradrenergic chromaffin cells. Over 60% of adren- 
ergic cells produced positive calcium responses, 
while only 45% of noradrenergic cells displayed 
molsidomine-evoked calcium responses. However, 
the average increase in the ratio evoked by 100 gM 
molsidomine was very similar in both chromaffin cell 
populations (0.54-4-0.07 in adrenergic and 0.57 ± 0.12 
in noradrenergic cells). Similar results were obtained 
when SNP and ISDN were used as NO-donors (data 
not shown). NO-responsive cells were not differen- 
tially segregated to NOS + and NOS chromaffin 
cells. The proportions of NO-responding ceils were 
63±5% and 60+7% for NOS + and NOS cells, 
respectively (Table 2C). However, the averaged 
ratio increases elicited by molsidomine in NOS + 
and NOS- cells were significantly higher in NOS- 
cells (0.48 4- 0.07 and 0.65 ± 0.06, respectively; 
Fig. 5A, B). 
The results of analysing all the data for the three 
NO-donors show the relative proportions of NO- 
donor-responsive cells among NOS + and NOS and 
between adrenergic and noradrenergic chromaffin 
cells to be that indicated in Table 3. No significant 
difference xists between the adrenergic (59±8%), 
noradrenergic (67 ± 16%) and total population 
(60 ± 7%) of NOS chromaffin cells while the relative 
proportion of NO-donor-responsive cells was 
significantly smaller in noradrenergic population of 
NOS + chromaffin cells (35 + 11% against 73 ± 6% in 
noradrenergic and adrenergic cells, respectively). 
DISCUSSION 
Previous tudies on the effects of NO in chromaffin 
or PC-12 cells have focused mainly on the effects 
on secretagogue-evoked catecholamine s cretion or 
[Ca2+]i increases. 6'32'33'36 Less attention has been 
paid to the direct action of NO on basal catechol- 
amine secretion and [Ca2+]i, an effect in which the 
NO may be considered more as a primary neuro- 
transmitter than a neuromodulator. This point 
appears to be somewhat controversial. Dohi et  al . ,  7 
working on perfused og adrenals, described a stimu- 
latory effect of nitro-compounds, including NO, in 
catecholamine secretion, but this enhancement of
catecholamine r lease was not observed in perfused 
cat adrenal medulla z4 nor in bovine cultured chrom- 
affin cells. 29 Here we have demonstrated that NO- 
donors elicit clear [Ca2+]i-increasing responses in 
bovine chromaffin cells in culture. Since Ca z+ is the 
direct trigger for catecholamine r lease, this result 
supports our previous finding that NO gas can 
elevate basal catecholamine s cretion. 27The [Ca2+]i 
increase elicited by NO donors was modest when 
compared with the responses to nicotine, but in 
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Table 1. Relative proportion of nitric oxide synthase-positive and negative cells in the whole 
chromaffin cell population (A) and within adrenergic and noradrenergic subpopulations (B) 
277 
NOS + NOS Total 
n % n % n 
(A) Whole population 512 534-2 459 47±2 971 
(B) Adrenergic ells 69 26 -4- 3(13) 193 74 ± 3(37) 262(50 -4- 2) P< 0.001 
Noradrenergic cells 213 82 =t- 2(42) 46 18 -4- 2 (9) 259(50 -4- 2) P<0.001 
(total) 282 54 + 2 239 46 ± 2 521 (P<0.001) 
The values within parenthesis are percentages calculated from the whole population. Data 
combining results from the three approaches indicated in Fig. 3. Collected from seven 
separate xperiments and counting 22 independent microscopic fields. Statistical analysis: 
± values were calculated as S.D. for a binomial distribution with the observed proportions. 
P values to the right represent testing the individual binomial proportion in each line against 
the 53% proportion observed in A. P value at the bottom right (in brackets) is the result of 
a X2-test for equal distribution of NOS in adrenergic and noradrenergic cells. 
Table 2. Relative proportion of chromaffin cells responding to nitric oxide donors with a [Ca2+]± 
increase in: (A) whole population; (B) adrenergic and noradrenergic cells and (C) nitric oxide 
synthase-positive and negative subpopulations of chromaffin cells 
[Ca2+]i-responsive [Ca2+]i-unresponsive 
n % n % total 
(A) Whole population 78 62 ± 4 47 38 -4- 4 125 
(B) Adrenergic ells 65 68 ± 5 31 32 -4- 5 96 
P<0.05 
Noradrenergic cells 13 45 ± 9 16 55 ± 9 29 
(C) NOS ÷ cells 52 63 4- 5 30 37 + 5 82 
N.S. 
NOS cells 26 60 ± 7 17 40 4- 7 43 
Data collected from nine different stimulations in three separate xperiments. The observed 
difference between adrenergic and noradrenergic cells was significant as judged from a 
%2-test. N.S., non-significant. 
proport ion with the relatively smaller effect of NO on 
catecholamine s cretion. In agreement with this view, 
the treatment of chromaffin cells with an analogue of 
cGMP,  the proposed second messenger for NO 
actions, elicited a small increase in [Ca2+]± .32 By using 
Fura-2 imaging techniques we have been able to 
reveal the heterogeneity of single cell responses to 
NO donors. Not all cells in a given culture displayed 
[Ca2+]± rises elicited by NO-donors.  Furthermore,  the 
time course of [Ca2+]i was highly variable, both in the 
onset and pattern of the response. Part of  this 
variabil ity may reside in the different kinetics of NO 
release by the NO-donors  used. In fact, the response 
to nicotine, a direct agonist of acetylcholine recep- 
tors, occurred almost in synchrony in all cells. 
This heterogeneity, together with the fact that only 
a subpopulat ion (624-4%) of chromaffin cells 
responded to NO donors with [Ca2+]± rises may 
explain why this effect has been elusive to others. 
Bovine chromaffin cells in culture are a very popu- 
lar model for the study of neurosecretion. In contrast 
to other species like guinea-pigs or chickens, bovine 
adrenal medulla contains both adrenergic and 
noradrenergic chromaffin cells. A l though the adren- 
ergic component  predominates in the intact gland 
(around 70%), the proport ion of adrenergic and 
noradrenergic cells in cultures varies with the method 
used for cell dissociation and purification. 23 Several 
studies have indicated that the distr ibution of recep- 
tors for ATP, 4 histamine, 5'26 angiotensin I126 or 
GABA 28 is differentially segregated to adrenergic 
or noradrenergic ells. Thus the question arises as 
Fig. 3. Immunofluorescence images showing the identification of chromaffin cells by specific enzymatic 
antibodies. Chromaffin cells were identified by immunostaining with specific antibodies as indicated in 
Experimental Procedures. (A) Double immunostaining of chromaffin cells with antibodies anti-TH (total 
population) and anti-nNOS (nitrergic cells). (B) Double immunostaining of chromaffin cells with 
antibodies anti-PNMT (adrenergic cells) and anti-nNOS (nitrergic ells). (C) Triple immunostaining of 
chromaffin cells with antibodies anti-TH (total population), PNMT (adrenergic cells) and anti-nNOS 
(nitrergic ells). In B and C, noradrenergic cells are stained by anti-TH but not by anti-PNMT antibodies. 
The plates are representative of several experiments, amounting to a total of 971 analysed cells. Scale 
bars= 50 ~tm. 
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Fig. 4. Distribution of chromaffin cell response to NO- 
donors in whole, adrenergic and noradrenergic chromaffin 
cell populations. (A, B) Frequency histograms showing the 
distribution of 100 pM molsidomine voked A ratio re- 
sponses in adrenergic and noradrenergic chromaffin cells. 
The average increase in the ratio was very similar in both 
chromaffin cell populations. The response was not signifi- 
cantly higher in any of these subpopulations (Student's 
t-test). 
to whether NO responses are correlated to the 
adrenergic/noradrenergic or NOS+/NOS phenotype 
of chromaffin cells. Immunoidentif ication of NO- 
responsive cells revealed that they were relatively 
more frequent among adrenergic ells than among 
noradrenergic cells. In the same way, the expression 
of NOS was not an unambiguous marker for the 
identification of NO-responsive cells, a lthough 
[Ca2+]i responses to NO donors were more frequent 
among NOS cells. As a result of the cumulative bias 
of the distr ibution of responses to NO donors in 
adrenergic/noradrenergic and NOS+/NOS cells, 
NO-evoked [Ca2+]i transients were significantly less 
abundant  among NOS ÷ noradrenergic ells. Thus, 
the proport ion of adrenergic/noradrenergic cells (as 
well as NOS+fNOS cells) in a mixed populat ion 
could significantly affect the average signal elicited by 
NO donors. 
In contrast to the incomplete segregation of 
responses to NO donors, we show here a clearly 
asymmetric distr ibution of NOS immunoreactivity 
among adrenergic and noradrenergic ells. NOS 
immunoreactivity is mainly (82±2%)  localized in 
PNMT-  chromaffin cells, despite noradrenergic cells 
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Fig. 5. Distribution of NO-donor-responsive cells between 
NOS + and NOS chromaffin cells. (A, B) Frequency histo- 
grams showing the distribution of 100/aM molsidomine 
evoked increases in A ratios in NOS + and NOS chromaffin 
cells. The average ratio increase was significantly higher in 
NOS chromaffin cells (P<0.01; Student's t-test). 
Table 3. Distribution of nitric oxide-donor esponsive 
cells among nitric oxide synthase-positive/negative and 
adrenergic/noradrenergic chromaffin cells 
Adrenergic Noradrenergic 
NOS + 73 ± 6% (45/62) 35 ± 11% (7/20) P<0.05 
NOS 59 ± 8% (20/34) 67 ± 16% (6/9) N.S. 
Data collected from nine different stimulations in three 
independent experiments. Statistical analysis: S.D. values 
were obtained assuming a binomial distribution. The 
whole table was tested for equal proportion hypothesis by 
both ANOVA and a Pearson X2-test. Both tests gave 
significant results at P=0.05, indicating unequal distribu- 
tion of NO-donor responsive cells. P values quoted 
correspond to a within-rows zZ-test. Results in parenthe- 
sis represent the number of responding cells against he 
total cell number (n= 125 cells). 
being in lower number  than adrenergic ells in the 
bovine adrenal gland. This result agrees with and 
extends previous data indicating that NOS was 
present only in a subpopulat ion of chromaffin cells in 
human j 5 and, not so clearly, in rat adrenal medulla. 9
These results point out that the information flow 
carried by NO within adrenal medulla travels mainly 
from noradrenergic cells (most NOS + cells are 
Nitric oxide and chromaffin cell heterogeneity 279 
PNMT ) to adrenergic ells (they are more abun- 
dant and mostly NOS and responsive to NO 
donors). In other words, NO may have a paracrine 
role, with noradrenergic ells specialized in the 
synthesis of NO whereas adrenergic ells constitute 
mainly the target of NO action. This view is stressed 
considering the short life and range of action of NO 
in a well-irrigated tissue like adrenal medulla. 
CONCLUSION 
Our results emphasize the importance of studying 
even relatively simple systems uch as adrenomedul- 
lary cultures at the cellular level and highlights the 
functional importance of chromaffin cell hetero- 
geneity in relation to NO actions. 
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